149 related articles for article (PubMed ID: 7511277)
1. [Tumor-like and preneoplastic lesions as well as low risk and high risk urothelial tumors].
Theuring F
Verh Dtsch Ges Pathol; 1993; 77():169-79. PubMed ID: 7511277
[TBL] [Abstract][Full Text] [Related]
2. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
Sibony M; Billerey C
Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
[TBL] [Abstract][Full Text] [Related]
3. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
[TBL] [Abstract][Full Text] [Related]
4. [Non-urothelial tumors of the urinary tract].
Mikuz G
Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
[TBL] [Abstract][Full Text] [Related]
5. [Hyperplastic-proliferative and preneoplastic lesions of the bladder urothelium (author's transl)].
Mattarozzi A; Zaniboni P; Zanella L; Bacchini P; Bertoni F
Pathologica; 1981; 73(1026):597-612. PubMed ID: 7312433
[No Abstract] [Full Text] [Related]
6. [Significance of AgNOR analysis of urothelial carcinomas].
Helpap B; Loesevitz L
Verh Dtsch Ges Pathol; 1993; 77():222-5. PubMed ID: 7511285
[TBL] [Abstract][Full Text] [Related]
7. Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder.
Montironi R; Lopez-Beltran A; Scarpelli M; Mazzucchelli R; Cheng L
Histopathology; 2008 Dec; 53(6):621-33. PubMed ID: 18422972
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
9. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
Blume B; Theuring F
Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
11. Flat intraepithelial lesions of the urinary bladder.
Cheng L; Cheville JC; Neumann RM; Bostwick DG
Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
14. DNA-variations in neighbouring epithelium in patients with bladder carcinoma.
Foss SD
Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):603-10. PubMed ID: 920179
[TBL] [Abstract][Full Text] [Related]
15. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
[TBL] [Abstract][Full Text] [Related]
16. [Dysplasias and carcinomas in situ of the urothelium].
Mihatsch MJ
Helv Chir Acta; 1985 Sep; 52(3-4):435-46. PubMed ID: 4066371
[No Abstract] [Full Text] [Related]
17. [Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors].
Bocharova OA; Serebriakova RV; Golubeva VA; Figurin KM; Bukharkin BV; Bodrova NB; Matveev BP; Baryshnikov AIu
Urol Nefrol (Mosk); 1994; (3):27-30. PubMed ID: 8079407
[TBL] [Abstract][Full Text] [Related]
18. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
Rao J; Seligson D; Visapaa H; Horvath S; Eeva M; Michel K; Pantuck A; Belldegrun A; Palotie A
Cancer; 2002 Sep; 95(6):1247-57. PubMed ID: 12216092
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]